EAT is up +49.38%% since April’24 pick View All Top Buy Picks

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of RVV.CN
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Revive Therapeutics Ltd. stock upgraded to Sell Candidate.
(Updated on Jun 28, 2024)

Sell candidate since Jun 17, 2024 Loss -50.00% PDF

No changes to the price of Revive Therapeutics Ltd. stock on the last trading day (Friday, 28th Jun 2024). During the last trading day the stock fluctuated 0% from a day low at $0.0100 to a day high of $0.0100. The price has been going up and down for this period, and there has been a -50% loss for the last 2 weeks.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.0093 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -38.10% during the next 3 months and, with a 90% probability hold a price between $0.0058 and $0.0140 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

RVV.CN Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, June 25, 2024, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Revive Therapeutics Ltd. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.0129 and $0.0216. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Buy
Special Signal Notification

Double Bottom Formation

Double Bottom Formation

Support, Risk & Stop-loss for Revive Therapeutics Ltd. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 46.67%

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (RVV.CN) For The Upcoming Trading Day Of Tuesday 2nd

For the upcoming trading day on Tuesday, 2nd we expect Revive Therapeutics Ltd. to open at $0.0100, and during the day (based on 14 day Average True Range), to move between $0.0072 and $0.0128, which gives a possible trading interval of +/-$0.0028 (+/-28.38%) up or down from last closing price. If Revive Therapeutics Ltd. takes out the full calculated possible swing range there will be an estimated 56.76% move between the lowest and the highest trading price during the day.

Is Revive Therapeutics Ltd. stock A Buy?

Revive Therapeutics Ltd. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -4.817 Sell Candidate Upgraded

Predicted Opening Price for Revive Therapeutics Ltd. of Tuesday, July 2, 2024

Fair opening price July 2, 2024 Current price
$0.0100 ( 0%) $0.0100

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for RVV.CN

Fibonacci Support & Resistance Levels

Level Price
R3 0.0100 -
R2 0.0100 -
R1 0.0100 -
Price 0.0100
S1 0.0100 -
S2 0.0100 -
S3 0.0100 -

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 0 -
Price 0.0100
S1 0 -
S2 0 -
S3 0 -

FAQ

What is the symbol for Revive Therapeutics Ltd. Stock and on which exchange is it traded?
The symbol for Revive Therapeutics Ltd. is RVV.CN and it is traded on the CNQ (Canadian Securities Exchange).

Should I buy or sell Revive Therapeutics Ltd. Stock?
Revive Therapeutics Ltd. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

How to buy Revive Therapeutics Ltd. Stock?
Revive Therapeutics Ltd. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Revive Therapeutics Ltd. Stock.

What's the current price of Revive Therapeutics Ltd. Stock?
As of the end of day on the Jun 28, 2024, the price of an Revive Therapeutics Ltd. (RVV.CN) share was $0.0100.

What is the 52-week high and low for Revive Therapeutics Ltd. Stock?
The 52-week high for Revive Therapeutics Ltd. Stock is $0.0600 and the 52-week low is $0.0050.

What is the market capitalization of Revive Therapeutics Ltd. Stock?
As of the Jun 28, 2024, the market capitalization of Revive Therapeutics Ltd. is 3.576M.

When is the next earnings date for Revive Therapeutics Ltd.?
The upcoming earnings date for Revive Therapeutics Ltd. is Dec 18, 2024.
Click to get the best stock tips daily for free!

About Revive Therapeutics Ltd.

Revive Therapeutics Ltd. Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics for rare disorders and infectious diseases. The company offers cannabinoid pharmaceutical portfolio that focuses on rare inflammatory diseases. It is developing Bucillamine, which is in Phase 3 clinical study for the treatment of infectious diseases, including influenza and COVID-19; Psilocybin that is in Phase 1 clinical study for treating ... RVV.CN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT